HEALTH

FDA advisory committee votes against Eisai-Arena obesity drug

BY Alaric DeArment

SAN DIEGO An advisory committee of the Food and Drug Administration has given a thumbs-down to a drug for treating obesity.

 

Eisai and Arena Pharmaceuticals said Thursday that the FDA’s Endocrinologic and Metabolic Drugs Advisory Committee voted 9-5 to recommend against approval of the drug lorcaserin, saying clinical trial data did not adequately show that its benefits would outweigh its risks.

 

 

While the FDA is not bound by advisory committee recommendations, it takes them into account when deciding whether or not to grant approval to a drug.

 

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

POLLS

Which area of the industry do you think Amazon’s entry would shake up the most?
HEALTH

Milk drinkers maintain healthy weight, study finds

BY Allison Cerra

WASHINGTON Milk drinkers are more likely to lose weight than those who skip drinking milk when on a diet, a study published in the American Journal of Clinical Nutrition suggested.

In a two-year study, researchers observed 300 overweight or at-risk men and women ages 40 to 65 years. The participants were put on low-fat, Mediterranean or low-carb diets for two years, but regardless of diet, those that consumed 580 mg of milk per day (about two glasses), lost about 12 lbs., compared with those with the lowest dairy calcium intake (averaging about 150 mg, or about half of a glass), in which participants lost just 7 lbs.

Beyond calcium, the researchers also found that vitamin D levels independently affected weight loss success, and, in line with previous research, milk and milk products were the top contributors to vitamin D in the diets of the study participants.

The study, "Dairy calcium intake, serum vitamin D and successful weight loss," was published in the Sept. 1 edition of the journal.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

POLLS

Which area of the industry do you think Amazon’s entry would shake up the most?
HEALTH

Sanofi-Aventis’ WISE program gets recognition from HBA

BY Alaric DeArment

FAIRFIELD, N.J. The Healthcare Businesswomen’s Association has given the U.S. subsidiary of French drug maker Sanofi-Aventis its 2010 HBA ACE Award for building women’s leadership in the company, the HBA said Thursday.

 

Sanofi-Aventis US won the award for its Women Inspiring Sanofi-Aventis Excellence, or WISE, program. WISE is an internal women’s network with more than 1,000 members designed to foster the leadership development of women working for the company. It has borrowed heavily from the HBA’s "Empowerment, Diversity, Growth, Excellence Leadership" study, conducted in 2007.

 

 

“The WISE program clearly demonstrates Sanofi-Aventis’ commitment to fostering the personal and professional leadership development of Sanofi-Aventis US women, which will have a direct impact on leadership in the healthcare industry overall,” HBA president Susan Torroella said. “We are proud that the ACE Award is recognizing this effort.”

 

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

POLLS

Which area of the industry do you think Amazon’s entry would shake up the most?